| IL179300A0 (en) | | Novel-antigen-binding polypeptides and their uses |
| EP1802588A4 (en) | | Substituted amino-pyrimidones and uses thereof |
| IL182554A0 (en) | | Anti-addl antibodies and uses thereof |
| EP1976864A4 (en) | | Novel peptide and use thereof |
| IL185308A0 (en) | | Replikin peptides and uses thereof |
| IL179497A0 (en) | | Carboranylporphyrins and uses thereof |
| ZA200700895B (en) | | Polypeptide |
| ZA200703406B (en) | | Anti-ADDL antibodies and uses thereof |
| IL180365A0 (en) | | Carboranylporphyrins and uses thereof |
| GB0324265D0 (en) | | Peptide |
| EP1705182A4 (en) | | Antitumoral and antiviral peptides |
| EP1840121A4 (en) | | Glycine derivative and use thereof |
| ZA200801874B (en) | | Antigenic peptides and their use |
| EP1953227A4 (en) | | Lipopolysaccharide- or lipid a-binder, and novel peptide |
| GB0324457D0 (en) | | Modified peptides and their uses |
| EP1824978A4 (en) | | Hcv f protein and uses thereof |
| HK1134030A1 (en) | | Survivin-derived peptides and use thereof |
| GB0415196D0 (en) | | Polypeptide |
| EP1735334A4 (en) | | Set1 proteins and uses therefor |
| IL160376A (en) | | Arp peptide and uses thereof |
| GB0425731D0 (en) | | Isolated peptides and uses thereof |
| GB0402904D0 (en) | | Polypeptide |
| EP1699809A4 (en) | | Amniotic-derived peptide and uses thereof |
| GB0516571D0 (en) | | Novel polypeptides and uses thereof |
| GB0427865D0 (en) | | Immunomodulatory peptides and uses therefor |